Research Article
Impact of Arterial Hypertension on Left Atrial Size and Function
Table 1
Demographic and clinical variables in 100 subjects of the population’s sample in which all data were available.
| Qualitative variables | | Proportion (%) |
| Men | 58 | 58 | Diabetic | 44 | 44 | Obese | 46 | 46 | Smoking | 17 | 17 | Menopause | 08 | 19 | Sedentary | 43 | 43 | Grade AHT II | 62 | 62 | Asymptomatic | 61 | 61 | Stroke | 03 | 03 | Stable angina | 06 | 06 | LVH on ECG | 26 | 26 | No added salt diet | 05 | 05 | CA | 20 | 20 | ACE | 39 | 39 | ARAII | 34 | 34 | BB | 19 | 19 | DT | 24 | 24 | Statin | 17 | 17 | Aspirin | 12 | 12 | Monotherapy | 47 | 47 | Dual therapy | 40 | 40 | Triple therapy | 13 | 13 |
| Quantitative variables | Means |
| Age (years) | 57,3 (41–79) | BMI (kg/m2) | 27,2 (21–36) | Hypertension duration (years) | 5,7 (1–8) | Systolic blood pressure (mmhg) | 12,72 (105–162) | Diastolic blood pressure (mmhg) | 78,3 (63–102) | Heart rate (bpm) | 63,2 (51–86) |
|
|
BMI: body mass index; CA: calcium antagonists; ACE: angiotensin-converting enzyme; ARAII: angiotensin II receptor antagonists; BB: beta-blockers; DT: diuretics; LVH: left ventricular hypertrophy; ECG: electrocardiogram.
|